west works side-by-side with healthcare partners from concept to the patient, designing and manufacturing packaging and delivery systems that promote efficiency, reliability and safety. west leads the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched knowledge of relevant pharmaceutical product testing, development and packaging. west supports customers from sales, manufacturing, and research and development locations in north and south america, europe, asia and australia.
Company profile
Ticker
WST
Exchange
Website
CEO
Eric Green
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
3M • Baxter International • Boston Scientific • Stryker • Becton Dickinson & Co. • Teleflex • Resmed • Haemonetics • Hill-Rom • Integra Lifesciences ...
Former names
WEST CO INC
SEC CIK
Corporate docs
Subsidiaries
West Pharmaceutical • Tech Group Europe Limited • Tech Group • TGPR Holdings Limited • West Services and Solutions, LLC • West Contract Manufacturing, LLC • West Pharma. Services IL, Ltd. • West Pharmaceutical Products Ireland, Ltd. • West Pharmaceutical Services Australia • West Pharmaceutical Services Group Limited ...
IRS number
231210010
WST stock data
Latest filings (excl ownership)
PX14A6G
Letter to shareholders
19 Mar 24
ARS
2023 FY
Annual report to shareholders
13 Mar 24
DEFA14A
Additional proxy soliciting materials
13 Mar 24
DEF 14A
Definitive proxy
13 Mar 24
PRE 14A
Preliminary proxy
1 Mar 24
10-K
2023 FY
Annual report
20 Feb 24
8-K
West Announces Fourth-Quarter and Full-Year 2023 Results
15 Feb 24
8-K
Entry into a Material Definitive Agreement
30 Nov 23
10-Q
2023 Q3
Quarterly report
26 Oct 23
8-K
West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend
26 Oct 23
Transcripts
WST
Earnings call transcript
2023 Q4
15 Feb 24
WST
Earnings call transcript
2023 Q3
26 Oct 23
WST
Earnings call transcript
2023 Q2
27 Jul 23
WST
Earnings call transcript
2023 Q1
27 Apr 23
WST
Earnings call transcript
2022 Q4
16 Feb 23
WST
Earnings call transcript
2022 Q3
27 Oct 22
WST
Earnings call transcript
2022 Q2
28 Jul 22
WST
Earnings call transcript
2022 Q1
28 Apr 22
WST
Earnings call transcript
2021 Q4
17 Feb 22
WST
Earnings call transcript
2021 Q3
28 Oct 21
Latest ownership filings
4
Chad Winters
12 Mar 24
4
Charles Witherspoon
1 Mar 24
4
Eric Mark Green
29 Feb 24
144
Notice of proposed sale of securities
27 Feb 24
4
Silji Abraham
27 Feb 24
4
Charles Witherspoon
22 Feb 24
4
Chad Winters
22 Feb 24
4
Cindy Reiss-Clark
22 Feb 24
4
Kimberly Banks MacKay
22 Feb 24
4
Quintin J Lai
22 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q3 2023
92.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 743 |
Opened positions | 97 |
Closed positions | 59 |
Increased positions | 234 |
Reduced positions | 290 |
13F shares | Current |
---|---|
Total value | 25.29 tn |
Total shares | 67.46 mm |
Total puts | 122.00 k |
Total calls | 114.30 k |
Total put/call ratio | 1.1 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 8.90 mm | $3.34 tn |
BLK Blackrock | 7.91 mm | $2.97 tn |
BK Bank Of New York Mellon | 3.39 mm | $1.27 tn |
STT State Street | 3.22 mm | $1.21 tn |
T. Rowe Price | 2.51 mm | $940.96 bn |
APG Asset Management | 2.11 mm | $790.54 bn |
BEN Franklin Resources | 2.08 mm | $779.53 bn |
T. Rowe Price Investment Management | 1.63 mm | $610.21 bn |
Geode Capital Management | 1.62 mm | $605.97 bn |
Artisan Partners Limited Partnership | 1.59 mm | $597.06 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Mar 24 | Chad Winters | Common Stock | Sell | Dispose S | No | No | 358.817 | 815 | 292.44 k | 1,308.698 |
11 Mar 24 | Chad Winters | Common Stock | Option exercise | Acquire M | No | No | 173.22 | 675 | 116.92 k | 2,123.698 |
11 Mar 24 | Chad Winters | Stock Options Stock Options (Right to Buy) | Option exercise | Dispose M | No | No | 173.22 | 675 | 116.92 k | 896 |
28 Feb 24 | Charles Witherspoon | Common Stock | Sell | Dispose S | No | No | 358.6238 | 2,019 | 724.06 k | 1,979.091 |
28 Feb 24 | Charles Witherspoon | Common Stock | Option exercise | Acquire M | No | No | 102.51 | 2,019 | 206.97 k | 3,998.091 |
28 Feb 24 | Charles Witherspoon | Stock Options Stock Options (Right to Buy) | Option exercise | Dispose M | No | No | 102.51 | 2,019 | 206.97 k | 529 |
27 Feb 24 | Green Eric Mark | Common Stock | Option exercise | Acquire M | No | Yes | 57.38 | 9,000 | 516.42 k | 152,908.125 |
27 Feb 24 | Green Eric Mark | Common Stock | Sell | Dispose S | No | Yes | 359.8511 | 64,132 | 23.08 mm | 152,908.125 |
27 Feb 24 | Green Eric Mark | Common Stock | Option exercise | Acquire M | No | Yes | 57.38 | 64,132 | 3.68 mm | 217,040.125 |
27 Feb 24 | Green Eric Mark | Stock Option Common Stock | Option exercise | Dispose M | No | No | 57.38 | 64,132 | 3.68 mm | 15,684 |
News
(WST) - Analyzing West Pharmaceutical Servs's Short Interest
26 Mar 24
S&P Reclaims 5,000 As Disappointing Retail Sales Put Fed Cuts Back On Track, Small Caps Shine: What's Driving Markets Thursday?
15 Feb 24
Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
15 Feb 24
West Pharmaceutical's 2024 Outlook Cautious, Analysts Remain Optimistic
15 Feb 24
(WST) - Analyzing West Pharmaceutical Servs's Short Interest
15 Feb 24
Press releases
West to Participate in Upcoming Investor Conferences
28 Feb 24
West Announces Second-Quarter 2024 Dividend
20 Feb 24
West Announces Fourth-Quarter and Full-Year 2023 Results
15 Feb 24
West Named to Newsweek's America's Greatest Workplaces 2024 for Diversity
7 Feb 24
West to Host Fourth-Quarter and Full-Year 2023 Conference Call
1 Feb 24